NEWS

Home› NEWS

NEWS

The 9th edition of the International Atherosclerosis Research School

The 2nd World Congress of Clinical Lipidology

Healthcare integrated biobanking and multiomics biomarker analysis

The 4th International Conference on Prehypertension, Hypertension and Cardio Metabolic Syndrome

The 3rd World Congress of Clinical Lipidology

41st Annual Scientific Meeting of the European Lipoprotein Club

New safety FDA information on statin therapy!

What awaits us regarding lipid disorders in 2012?

Co-operation between PoLA and Archives of Medical Science and American Society for Preventive Cardiology (ASPC)

Addressing Residual Risk in the ACS Patient: Knowing the Numbers!

Merry Christmas and Happy New Year AD 2012!

Large discussion on AIM-HIGH

Should we use statins in elderly population?

Despite robust clinical trial evidence, a substantial number of patients with obstructive CAD remain untreated with statins!

Maximum doses of rosuvastatin and atorvastatin equally regress atherosclerosis - results of SATURN Trial

Blood Pressure, Lipids and Glucose in Type 2 Diabetes - How Low Should We Go?

Board Meeting of National Lipid Assocation (NLA), 12th Nov. 2011, Orlando

Board Meeting of American Society of Preventive Cardiology (ASPC) - Orlando, 12th Novembr 2011.

Cautious Optimism Welcomes New CETP Inhibitor - evacetrapib

Statins Are Safe and Effective - 11-year follow-up of HPS study

I Congress of Polish Lipid Association (PoLA) - Warsaw, September 2011.

Join PoLA on Facebook Join PoLA on LinkedIn and join PoLA forum

Partners:

National Lipid Association

Polskie Towarzystwo Badań nad Miażdżycą

American Society for Preventive Cardiology

Polskie Towarzystwo Badań nad Otyłością

Home Events PoLA NEWS Journals Contact

Polish Lipid Association
ul. Kleeberga 2
61-615 Poznań
tel./faks: +48 61 822 77 81

© 2011 Polish Lipid Association. All rights reserved.